Novartis could sell more drugs through direct-to-patient servicenews2025-10-28T10:53:05+00:00October 28th, 2025|Endpoints News|
Cigna says it will end drug rebates as pressure mounts on PBMsnews2025-10-27T18:47:43+00:00October 27th, 2025|Endpoints News|
Cigna says it will end drug rebates as pressure mounts on PBMsnews2025-10-27T18:47:43+00:00October 27th, 2025|Endpoints News|
Organon CEO exits after internal probe over ‘channel stuffing’ to boost salesnews2025-10-27T18:29:50+00:00October 27th, 2025|Endpoints News|
Organon CEO exits after internal probe over ‘channel stuffing’ to boost salesnews2025-10-27T18:29:50+00:00October 27th, 2025|Endpoints News|
Intellia pauses two CRISPR trials after liver toxicity hospitalizes patientnews2025-10-27T16:48:44+00:00October 27th, 2025|Endpoints News|
Intellia pauses two CRISPR trials after liver toxicity hospitalizes patientnews2025-10-27T16:48:44+00:00October 27th, 2025|Endpoints News|
Verily CEO discusses personal health records launch, spinoff prepnews2025-10-27T16:00:43+00:00October 27th, 2025|Endpoints News|
Verily CEO discusses personal health records launch, spinoff prepnews2025-10-27T16:00:43+00:00October 27th, 2025|Endpoints News|
FDA names Mary Thanh Hai as permanent director of Office of New Drugsnews2025-10-27T15:48:22+00:00October 27th, 2025|Endpoints News|
